Dr. Janice E. Parente, president and founder of ethica CRO, explains what led her company to work with pharmaceutical companies internationally and how ethica CRO’s accreditations are an emblem of excellence. Furthermore, she presents ideas on how Canada could be more competitive in terms of R&D globally, by converting its weaknesses into strengths, and focusing on niche studies.
Janice, how did ethica CRO come to exist and what does it stand for today?
"Canada could find advantage by positioning itself as a country of excellence for smaller studies or more complex studies requiring innovative designs, the type ethica CRO has excelled with in the past."
